ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 984,93
-0,99%
Dow Jones
37 903,29
0,23%
DAX
17 932,17
-1,10%
Brent Oil
83,605
0,08%
Bitcoin
57 146,63
-1,87%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Agios Pharmaceuticals Inc (AGIO)

  7. Agios Pharmaceuticals Inc (AGIO) Actualités

AGIO Agios Pharmaceuticals Inc

32,60
0,10 (0,31%)
01 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Agios Pharmaceuticals Inc AGIO NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,10 0,31% 32,60 23:57:49
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
32,30 32,30 34,58 33,66 32,50
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
18/4/202413:00GLOBEAgios to Webcast Conference Call of First Quarter 2024..
09/4/202413:00GLOBEAgios Publishes 2024 Environmental, Social and Governance..
08/3/202400:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202422:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202422:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202422:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202413:00GLOBEAgios to Present at the Leerink Partners Global Biopharma..
01/3/202422:27EDGAR2Form 144 - Report of proposed sale of securities
01/3/202422:26EDGAR2Form 144 - Report of proposed sale of securities
01/3/202422:25EDGAR2Form 144 - Report of proposed sale of securities
01/3/202422:22EDGAR2Form 144 - Report of proposed sale of securities
29/2/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202422:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202403:21EDGAR2Form 144 - Report of proposed sale of securities
22/2/202423:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202413:00GLOBEAgios to Present at the TD Cowen 44th Annual Health Care..
15/2/202416:33EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
15/2/202413:03EDGAR2Form 8-K - Current report
15/2/202413:00GLOBEAgios Reports Fourth Quarter and Full Year 2023 Financial..
14/2/202423:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202423:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202423:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202420:21EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202420:06EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
02/2/202413:00GLOBEAgios to Webcast Conference Call of Fourth Quarter and Year..
24/1/202422:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202422:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202422:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202422:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202422:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/1/202422:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/1/202422:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/1/202422:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202413:58EDGAR2Form 8-K - Current report
08/1/202413:00GLOBEAgios Announces Key Anticipated 2024 Milestones Across Rare..
05/1/202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202412:30GLOBEAgios Announces Phase 3 ENERGIZE Study of Mitapivat Met..
02/1/202413:00GLOBEAgios to Present at the 42nd Annual J.P. Morgan Healthcare..
10/12/202301:00GLOBEAgios Presents Positive Results from Phase 2 Portion of the..
20/11/202313:00GLOBEAgios Announces Clinical Proof-of-Concept in Phase 2a Trial..
02/11/202314:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/11/202314:05GLOBEAgios Pharmaceuticals to Present Broad Set of Clinical and..
02/11/202312:02EDGAR2Form 8-K - Current report
02/11/202312:00GLOBEAgios Reports Business Highlights and Third Quarter 2023..
28/9/202322:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/8/202313:00GLOBEAgios to Present at the Morgan Stanley Global Healthcare..
21/8/202322:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/8/202322:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Dernières Valeurs Consultées

NASDAQ
AGIO
Agios Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés